| dbo:abstract |
Spiramide (developmental code name AMI-193) is an experimental antipsychotic that acts as a selective 5-HT2A, 5-HT1A, and D2 receptor antagonist. It has negligible affinity for the 5-HT2C receptor. (en) スピラミド(Spiramide)は、、及びのアンタゴニストであるが、へのアフィニティーはない。 (ja) Спирамид (AMI-193) — селективный антагонист 5-HT2A, 5-HT1A и D2 рецепторов, антипсихотик. Он имеет пренебрежимо малую аффинность к 5-HT2C-рецепторам. (ru) |
| dbo:casNumber |
510-74-7 |
| dbo:chEBI |
64207 |
| dbo:fdaUniiCode |
471LF4O004 |
| dbo:pubchem |
68186 |
| dbo:thumbnail |
wiki-commons:Special:FilePath/AMI-193_structure.png?width=300 |
| dbo:wikiPageID |
23235264 (xsd:integer) |
| dbo:wikiPageLength |
3030 (xsd:nonNegativeInteger) |
| dbo:wikiPageRevisionID |
1080597289 (xsd:integer) |
| dbo:wikiPageWikiLink |
dbc:Fluoroarenes dbc:Lactams dbc:Nitrogen_heterocycles dbc:Phenol_ethers dbc:Spiro_compounds dbr:Antipsychotic dbr:Receptor_antagonist dbr:Pharmacodynamics dbr:Receptor_(biochemistry) dbc:Butyrophenone_antipsychotics dbr:Affinity_(pharmacology) dbr:Binding_selectivity dbr:D2_receptor dbr:5-HT1A dbr:5-HT2A dbr:5-HT2C |
| dbp:atcPrefix |
none (en) |
| dbp:c |
22 (xsd:integer) |
| dbp:casNumber |
510 (xsd:integer) |
| dbp:chebi |
64207 (xsd:integer) |
| dbp:chemspiderid |
61493 (xsd:integer) |
| dbp:f |
1 (xsd:integer) |
| dbp:h |
27 (xsd:integer) |
| dbp:iupacName |
8 (xsd:integer) |
| dbp:iupharLigand |
175 (xsd:integer) |
| dbp:n |
3 (xsd:integer) |
| dbp:o |
2 (xsd:integer) |
| dbp:pubchem |
68186 (xsd:integer) |
| dbp:smiles |
c2ccccc2OCCCN3CCC1Nc4ccccc4 (en) |
| dbp:stdinchi |
1 (xsd:integer) |
| dbp:stdinchikey |
FJUKDAZEABGEIH-UHFFFAOYSA-N (en) |
| dbp:title |
dbr:Pharmacodynamics |
| dbp:titlestyle |
background:#ccccff (en) |
| dbp:unii |
471 (xsd:integer) |
| dbp:verifiedrevid |
443306099 (xsd:integer) |
| dbp:width |
250 (xsd:integer) |
| dbp:wikiPageUsesTemplate |
dbt:Drugbox dbt:Navboxes dbt:Nervous-system-drug-stub dbt:Reflist dbt:Serotonin_receptor_modulators dbt:Short_description dbt:Drugbankcite dbt:Ebicite dbt:Fdacite dbt:Xenobiotic-sensing_receptor_modulators dbt:Dopamine_receptor_modulators |
| dcterms:subject |
dbc:Fluoroarenes dbc:Lactams dbc:Nitrogen_heterocycles dbc:Phenol_ethers dbc:Spiro_compounds dbc:Butyrophenone_antipsychotics |
| gold:hypernym |
dbr:HT |
| rdf:type |
owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 yago:WikicatMolecularFormulas yago:WikicatNitrogenHeterocycles yago:Abstraction100002137 yago:Chemical114806838 yago:Communication100033020 yago:Compound114818238 yago:Element114840755 yago:Formula106816935 yago:HeterocyclicCompound115025397 yago:Material114580897 yago:Matter100020827 yago:Message106598915 yago:MolecularFormula106817173 yago:Part113809207 yago:PhysicalEntity100001930 yago:Quintessence114847103 yago:Relation100031921 dbo:Drug yago:Statement106722453 yago:Substance100019613 yago:WikicatPhenolEthers |
| rdfs:comment |
Spiramide (developmental code name AMI-193) is an experimental antipsychotic that acts as a selective 5-HT2A, 5-HT1A, and D2 receptor antagonist. It has negligible affinity for the 5-HT2C receptor. (en) スピラミド(Spiramide)は、、及びのアンタゴニストであるが、へのアフィニティーはない。 (ja) Спирамид (AMI-193) — селективный антагонист 5-HT2A, 5-HT1A и D2 рецепторов, антипсихотик. Он имеет пренебрежимо малую аффинность к 5-HT2C-рецепторам. (ru) |
| rdfs:label |
スピラミド (ja) Spiramide (en) Спирамид (ru) |
| owl:sameAs |
freebase:Spiramide wikidata:Spiramide dbpedia-ja:Spiramide dbpedia-ru:Spiramide dbpedia-sh:Spiramide dbpedia-sr:Spiramide dbpedia-vi:Spiramide https://global.dbpedia.org/id/4vyHy yago-res:Spiramide |
| prov:wasDerivedFrom |
wikipedia-en:Spiramide?oldid=1080597289&ns=0 |
| foaf:depiction |
wiki-commons:Special:FilePath/AMI-193_structure.png |
| foaf:isPrimaryTopicOf |
wikipedia-en:Spiramide |
| is dbo:wikiPageRedirects of |
dbr:C22H27FN3O2 dbr:AMI-193 |
| is dbo:wikiPageWikiLink of |
dbr:C22H27FN3O2 dbr:5-HT1A_receptor dbr:Fluspirilene dbr:List_of_drugs:_Sp–Sub dbr:AMI-193 |
| is foaf:primaryTopic of |
wikipedia-en:Spiramide |
